Axonometrysp. z o.o.
Manufacture of irradiation, electromedical and electrotherapeutic equipment
Overview
Axonometry develops medical technologies, including the SEYY app for speech rehabilitation after a stroke. It also offers an EMG device for electrophysiological testing of muscles and the nervous system.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2021-10-01. Active
78 1090 0088 0000 0001 4503 1365
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 30, 2022 | Aid for SME access to finance — aid for start-ups | $179.5K$179,453 | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Sep 30, 2021 | Aid for SME access to finance — aid for start-ups | $258.6K$258,556 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Jun 18, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $12,197$12,197 | Puławski Park Naukowo - Technologiczny sp. z o.o. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-11-01 | Opracowanie i wdrożenie systemu Axonometry wraz z aplikacjami mobilnymi, współpracującego z autorskim czujnikiem EMG i służącego do rehabilitacji zaburzeń mowy powstałych w wyniku udaru. | $258.6K$258,556 | Program Operacyjny Polska Wschodnia |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Miłosz Marek Jamroży (41) | 31 | $837.39 | 19.6203% |
Paweł Konrad Michaluk (43) | 20 | $540.25 | 12.6582% |
| 21 | $567.26 | 13.2911% | |
Bartosz Adrian Turczynowicz (40) | 83 | $2,242.03 | 52.5316% |
Others | 3 | $81.04 | 1.8988% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| SeemoreS.A. | $183,011.11 | seemore.pl | ||
| Brain Opticssp. z o.o. | $103,370.62 | brainoptics.eu | ||
| Neures Polskasp. z o.o. | $73,072.02 | neures.pl | ||
| Inventmedsp. z o.o. | $73,620.90 | inventmed.pl | ||
| Proemdrsp. z o.o. | $25,254.32 | proemdr.com | ||
| NLA Systemssp. z o.o. | $24,304.69 | nla-systems.com | ||
| Imaginertsp. z o.o. | $10,275.04 | imaginert.com.pl | ||
| ScansoftS.A. | $7,871.06 | healthnomic.pl |
Change history
| Date | Event | |
|---|---|---|
| 2022-04-14 | Share capital change (13,700.00 PLN → 15,800.00 PLN) | |
| 2022-03-31 | Share capital change (10,000.00 PLN → 13,700.00 PLN) | |
| 2020-06-08 | Entered in the register |
FAQ
Last updated: 2026-07-16